157 related articles for article (PubMed ID: 8905900)
1. Free beta hCG screening of hydropic and non-hydropic Turner syndrome pregnancies.
Laundon CH; Spencer K; Macri JN; Anderson RW; Buchanan PD
Prenat Diagn; 1996 Sep; 16(9):853-6. PubMed ID: 8905900
[TBL] [Abstract][Full Text] [Related]
2. Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.
Wenstrom KD; Boots LR; Cosper PC
J Matern Fetal Med; 1996; 5(1):31-5. PubMed ID: 8796763
[TBL] [Abstract][Full Text] [Related]
3. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
4. Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.
Lambert-Messerlian GM; Saller DN; Tumber MB; French CA; Peterson CJ; Canick JA
Prenat Diagn; 1998 Oct; 18(10):1061-7. PubMed ID: 9826898
[TBL] [Abstract][Full Text] [Related]
5. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
6. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
7. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
8. hCG and the free beta-subunit as screening tests for Down syndrome.
Knight GJ; Palomaki GE; Neveux LM; Fodor KK; Haddow JE
Prenat Diagn; 1998 Mar; 18(3):235-45. PubMed ID: 9556040
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
10. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
11. Extreme second-trimester serum analyte values in down syndrome pregnancies with hydrops fetalis.
Benn PA; Egan JF; Ingardia CJ
J Matern Fetal Neonatal Med; 2002 Apr; 11(4):262-5. PubMed ID: 12375682
[TBL] [Abstract][Full Text] [Related]
12. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
13. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
14. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
16. The detection of non-immune hydrops through second-trimester maternal serum screening.
Saller DN; Canick JA; Oyer CE
Prenat Diagn; 1996 May; 16(5):431-5. PubMed ID: 8844001
[TBL] [Abstract][Full Text] [Related]
17. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
18. Elevated second-trimester maternal serum β-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome.
Alvarez-Nava F; Soto M; Lanes R; Pons H; Morales-Machin A; Bracho A
J Obstet Gynaecol Res; 2015 Dec; 41(12):1891-8. PubMed ID: 26369382
[TBL] [Abstract][Full Text] [Related]
19. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin.
Bartha JL; Omar KM; Soothill PW
Prenat Diagn; 2004 Aug; 24(8):609-12. PubMed ID: 15305347
[TBL] [Abstract][Full Text] [Related]
20. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
